Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Prognosis of hepatocellular carcinoma: the BCLC staging classification.

Llovet JM, Brú C, Bruix J.

Semin Liver Dis. 1999;19(3):329-38.

PMID:
10518312
2.

Updated treatment approach to hepatocellular carcinoma.

Llovet JM.

J Gastroenterol. 2005 Mar;40(3):225-35. Review.

PMID:
15830281
4.

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials.

Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso Mdel C, Sala M, Brú C, Rodés J, Bruix J.

Hepatology. 1999 Jan;29(1):62-7.

PMID:
9862851
5.

Comparison of three current staging systems for hepatocellular carcinoma: Japan integrated staging score, new Barcelona Clinic Liver Cancer staging classification, and Tokyo score.

Chung H, Kudo M, Takahashi S, Hagiwara S, Sakaguchi Y, Inoue T, Minami Y, Ueshima K, Fukunaga T, Matsunaga T.

J Gastroenterol Hepatol. 2008 Mar;23(3):445-52. Epub 2007 Aug 6.

PMID:
17683486
6.

Current strategy for staging and treatment: the BCLC update and future prospects.

Forner A, Reig ME, de Lope CR, Bruix J.

Semin Liver Dis. 2010 Feb;30(1):61-74. doi: 10.1055/s-0030-1247133. Epub 2010 Feb 19. Review.

PMID:
20175034
7.

Prognosis of hepatocellular carcinoma in anti-HCV positive cirrhotic patients: a single-centre comparison amongst four different staging systems.

Giannini E, Risso D, Botta F, Romagnoli P, Malfatti F, Fumagalli A, Testa E, Podestà E, Chiarbonello B, Polegato S, Testa R.

J Intern Med. 2004 Mar;255(3):399-408.

8.

Treatment of hepatocellular carcinoma.

Forner A, Hessheimer AJ, Isabel Real M, Bruix J.

Crit Rev Oncol Hematol. 2006 Nov;60(2):89-98. Epub 2006 Jul 24. Review.

PMID:
16860993
9.

The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - Survival analysis of 3892 patients.

Wang JH, Changchien CS, Hu TH, Lee CM, Kee KM, Lin CY, Chen CL, Chen TY, Huang YJ, Lu SN.

Eur J Cancer. 2008 May;44(7):1000-6. doi: 10.1016/j.ejca.2008.02.018. Epub 2008 Mar 11.

PMID:
18337087
10.

Prospective validation of the Barcelona Clinic Liver Cancer staging system.

Cillo U, Vitale A, Grigoletto F, Farinati F, Brolese A, Zanus G, Neri D, Boccagni P, Srsen N, D'Amico F, Ciarleglio FA, Bridda A, D'Amico DF.

J Hepatol. 2006 Apr;44(4):723-31. Epub 2006 Jan 24.

PMID:
16488051
11.

The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available?

Cillo U, Bassanello M, Vitale A, Grigoletto FA, Burra P, Fagiuoli S, D'Amico F, Ciarleglio FA, Boccagni P, Brolese A, Zanus G, D'Amico DF.

J Hepatol. 2004 Jan;40(1):124-31.

PMID:
14672623
12.

Prognostic prediction in patients with hepatocellular carcinoma.

Sala M, Forner A, Varela M, Bruix J.

Semin Liver Dis. 2005;25(2):171-80. Review.

PMID:
15918146
13.

Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona Clinic Liver Cancer classification: results of a prospective analysis.

Torzilli G, Donadon M, Marconi M, Palmisano A, Del Fabbro D, Spinelli A, Botea F, Montorsi M.

Arch Surg. 2008 Nov;143(11):1082-90. doi: 10.1001/archsurg.143.11.1082.

PMID:
19015467
14.

Prognosis of hepatocellular carcinoma in relation to treatment across BCLC stages.

D'Avola D, Iñarrairaegui M, Pardo F, Rotellar F, Marti P, Bilbao JI, Martinez-Cuesta A, Benito A, Alegre F, Mauleón E, Herrero JI, Quiroga J, Prieto J, Sangro B.

Ann Surg Oncol. 2011 Jul;18(7):1964-71. doi: 10.1245/s10434-011-1551-4. Epub 2011 Jan 26.

PMID:
21267791
15.

Comparison of the usefulness of three staging systems for hepatocellular carcinoma (CLIP, BCLC, and JIS) in Japan.

Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J.

Am J Gastroenterol. 2005 Aug;100(8):1764-71.

PMID:
16086713
16.

The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma.

Llovet JM, Fuster J, Bruix J; Barcelona-Clínic Liver Cancer Group.

Liver Transpl. 2004 Feb;10(2 Suppl 1):S115-20. Review.

17.

The prognosis and survival analysis according to seven staging systems of hepatocellular carcinoma following curative resection.

Choi SB, Lee JG, Kim KS, Yoon DS, Choi JS, Lee WJ, Kim BR.

Hepatogastroenterology. 2008 Nov-Dec;55(88):2140-5.

PMID:
19260493
18.

Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment.

Vauthey JN, Ribero D, Abdalla EK, Jonas S, Bharat A, Schumacher G, Lerut J, Chapman WC, Hemming AW, Neuhaus P.

J Am Coll Surg. 2007 May;204(5):1016-27; discussion 1027-8.

PMID:
17481532
20.

Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia.

Han KH, Kudo M, Ye SL, Choi JY, Poon RT, Seong J, Park JW, Ichida T, Chung JW, Chow P, Cheng AL.

Oncology. 2011;81 Suppl 1:158-64. doi: 10.1159/000333280. Epub 2011 Dec 22.

PMID:
22212951

Supplemental Content

Support Center